Table 4 Unadjusted survival rates in overall and resected pancreatic cancer patients diagnosed in 2003–2005, 2006–2008, and 2009–2011

1 month

2003–2005

I–II

83 (82–84)

95 (94–96)

89 (87–91)

96 (93–97)

94 (92–96)

97 (94–98)

91 (88–94)

99 (94–100)

89 (84–93)

96 (90–98)

III–IV

61 (60–62)

86 (82–89)

73 (71–75)

88 (74–95)

88 (85–90)

96 (86–99)

78 (75–80)

100 (100–100)

69 (65–74)

92 (71–98)

2006–2008

I–II

84 (84–85)

96 (95–96)

92 (91–94)

97 (95–98)

95 (94–97)

97 (95–98)

90 (83–96)

99 (93–100)

93 (88–96)

99 (93–100)

III–IV

62 (61–63)

89 (86–91)

77 (75–78)

100 (100–100)

86 (85–88)

98 (91–99)

79 (76–81)

96 (75–99)

75 (71–78)

97 (80–100)

2009–2011

I–II

86 (85–87)

96 (96–97)

92 (90–93)

97 (96–98)

96 (95–97)

98 (97–99)

94 (91–96)

98 (95–99)

90 (85–94)

99 (94–100)

III–IV

63 (62–64)

90 (88–92)

76 (75–78)

91 (81–96)

85 (84–87)

100 (100–100)

78 (75–80)

96 (77–100)

75 (72–79)

98 (86–100)

Percent unit change,^b P

I–II

+ 3, 0.006

+ 2, 0.004

+ 3, 0.021

+ 1, 0.257

+ 2, 0.116

+ 1, 0.577

+ 3, 0.175

–1, 0.473

+ 1, 0.851

+ 4, 0.083

III–IV

+ 2, 0.002

+ 4, 0.989

+ 3, 0.001

+ 3, 0.635

–2, 0.086

+4, 0.189

+ < 1, 0.972

−4, 0.301

+ 6, 0.024

+ 6, 0.229

3 months

2003–2005

I–II

72 (71–73)

91 (90–92)

74 (71–76)

92 (89–94)

86 (83–89)

93 (90–96)

76 (71–80)

98 (93–99)

76 (69–82)

87 (79–92)

III–IV

42 (41–43)

74 (69–78)

42 (40–43)

84 (69–92)

66 (62–69)

93 (82–97)

44 (41–47)

87 (68–95)

36 (31–40)

58 (36–75)

2006–2008

I–II

73 (72–74)

92 (91–92)

78 (76–81)

93 (91–95)

87 (85–89)

92 (90–94)

72 (67–76)

94 (86–97)

80 (73–86)

92 (85–96)

III–IV

44 (43–44)

79 (76–82)

46 (44–47)

98 (88–100)

63 (61–65)

85 (95–91)

48 (46–51)

84 (63–94)

43 (39–47)

85 (67–93)

2009–2011

I–II

76 (75–77)

93 (92–94)

80 (78–82)

93 (91–95)

89 (87–91)

94 (92–96)

82 (78–85)

96 (92–98)

76 (70–82)

97 (91–99)

III–IV

45 (44–46)

81 (78–84)

45 (43–46)

85 (74–92)

63 (60–65)

93 (85–96)

47 (44–49)

86 (66–94)

44 (40–48)

76 (61–86)

Percent unit change,^b P

I–-II

+ 4, < 0.001

+ 2, < 0.001

+ 6, 0.001

+ 1, 0.546

+ 3, 0.118

+ 1, 0.508

+ 6, 0.035

− 1, 0.562

+ < 1, 0.909

+ 10, 0.005

III–IV

+ 3, < 0.001

+ 7, 0.017

+ 3, 0.001

+ 1, 0.831

−3, 0.087

– < 1, 0.972

+ 3, 0.225

−1, 0.890

+ 8, 0.007

+ 18, 0.085

12 months

2003–2005

I–II

38 (36–39)

64 (62–66)

33 (30–36)

64 (59–68)

52 (48–57)

62 (56–67)

34 (29–39)

66 (57–74)

38 (30–45)

51 (41–60)

III–IV

11 (11–12)

34 (29–39)

8 (7–9)

49 (33–63)

19 (17–22)

45 (31–57)

8 (6–10)

37 (20–53)

5 (3–8)

13 (3–29)

2006–2008

I–II

40 (39–41)

65 (64–67)

36 (33–38)

64 (60–68)

56 (53–60)

69 (65–73)

33 (29–38)

71 (60–79)

51 (43–59)

67 (57–76)

III–IV

12 (12–13)

35 (31–39)

8 (7–9)

53 (38–64)

19 (17–21)

47 (36–57)

11 (10–13)

56 (35–73)

12 (10–15)

39 (23–55)

2009–2011

I–II

44 (43–45)

70 (68–71)

45 (43–48)

69 (65–72)

55 (52–57)

68 (65–71)

44 (39–49)

77 (70–83)

42 (35–48)

60 (50–68)

III–IV

14 (14–15)

47 (42–51)

9 (8–10)

41 (29–52)

20 (18–22)

53 (42–62)

10 (8–11)

46 (28–63)

11 (9–14)

17 (8–30)

Percent unit change,^b P

I–II

+ 6, <  0.001

+ 5, < 0.001

+ 12, < 0.001

+ 5, 0.066

+ 3, 0.297

+ 6, 0.057

+ 10, 0.003

+ 11, 0.025

+ 4, 0.577

+ 9, 0.101

III–IV

+ 3, <  0.001

+ 13, < 0.001

+ 1, 0.001

−8, 0.496

+ 1, 0.476

+ 8, 0.548

+ 2, 0.027

+ 10, 0.689

+ 6, < 0.001

+ 5, 0.238

Survival

Period

Stage

Overall

Resected

Overall

Resected

Overall

Resected

Overall

Resected

Overall

Resected

OS (95% CI)¹

OS (95% CI)

OS (95% CI)

OS (95% CI)

OS (95% CI)

OS (95% CI)

OS (95% CI)

OS (95% CI)

OS (95% CI)

OS (95% CI)

36 months

2003–2005

I–II

13 (13–14)

27 (25–29)

8 (7–10)

18 (14–22)

17 (14–21)

24 (19–29)

12 (9–16)

28 (20–36)

9 (6–14)

11 (6–17)

III–IV

2 (2–2)

7 (5–10)

1 (1–2)

14 (6–26)

2 (2–4)

8 (2–16)

1 (1–2)

10 (3–24)

1 (< 1–2)

NA

2006–2008

I–II

14 (14–15)

29 (27–30)

12 (10–13)

24 (20–28)

21 (18–23)

28 (25–32)

10 (7–14)

32 (22–41)

19 (14–26)

27 (19–37)

III–IV

2 (2–2)

9 (7–11)

1 (1–1)

11 (5–21)

2 (2–3)

7 (3–14)

2 (1–2)

24 (10–42)

2 (1–3)

12 (4–26)

2009–2011

I–II

17 (16–18)

33 (31–34)

16 (15–18)

29 (26–32)

20 (18–22)

30 (26–33)

15 (12–18)

30 (23–37)

12 (8–16)

17 (11–24)

III–IV

2 (2–2)

11 (9–14)

1 (1–1)

12 (6–21)

2 (1–3)

10 (5–16)

1 (1–2)

14 (5–30)

1 (< 1–1)

NA

Percent unit change,^b P

I–II

+4, < 0.001

+ 5, < 0.001

+ 8, < 0.001

+ 11, < 0.001

+ 3, 0.076

+ 5, 0.035

+ 2, 0.025

+ 2, 0.205

+ 2, 0.468

+ 6, 0.069

III–IV

+ < 1, < 0.001

+ 5, < 0.001

+ < 1, 0.005

−2, 0.886

−1, 0.285

+ 2, 0.317

– < 1, 0.062

+4, 0.785

+ < 1, 0.002

NA, NA

60 months

2003–2005

I–II

9 (8–10)

18 (17–20)

4 (3–5)

10 (7–13)

11 (8–14)

16 (12–21)

9 (6–12)

18 (12–25)

7 (3–11)

9 (5–15)

III–IV

1 (1–1)

4 (2–6)

1 (< 1–1)

9 (3–20)

1 (< 1–2)

4 (1–11)

1 (< 1–1)

3 (< 1–15)

< 1 (< 1–1)

NA

2006–2008

I–II

10 (9–11)

20 (19–21)

7 (6–9)

15 (12–19)

13 (11–15)

18 (15–21)

7 (4–9)

20 (12–28)

9 (5–14)

13 (7–21)

III–IV

1 (1–1)

6 (5–9)

< 1 (< 1–1)

6 (2–14)

1 (1–2)

5 (2–11)

1 (< 1–1)

4 (< 1–17)

2 (1–3)

12 (4–26)

2009–2011

I–II

NA

NA

10 (8–12)

18 (15–21)

12 (10–14)

18 (15–21)

10 (7–13)

20 (14–27)

8 (5–12)

11 (6–17)

III–IV

NA

NA

1 (< 1–1)

12 (6–21)

1 (< 1–1)

2 (< 1–7)

< 1 (< 1–1)

NA

< 1 (< 1–1)

NA

Percent unit change,^b P

I–II

NA, NA

NA, NA

+ 6, < 0.001

+ 8, < 0.001

+ 1, 0.109

+ 2, 0.090

+ 1, 0.043

+ 2, 0.262

+ 2, 0.469

+ 2, 0.113

III–IV

NA, NA

NA, NA

+ < 1, 0.004

+ 3, 0.935

–< 1, 0.290

−2, 0.409

- < 1, 0.069

NA, NA

+ < 1, 0.002

NA, NA